Eric Meier, PhD

Dr. Eric J.M. Meier is Head QA Continuous Manufacturing at Novartis Pharma AG. Within global technical research and development quality assurance he is responsible for all quality aspects of continuous manufacturing including the GMP readiness and the implementation of the pharmaceutical quality system. Eric joined Novartis in 2011 where he served as Quality Site Head for the solid dosage form manufacturing site in Switzerland. He started his career as Head Quality Control in a pharmaceutical company producing solid, semi-solid, liquid dosage forms and synthetic API’s. Then he moved to Quality Assurance and was responsible for the Quality Units (QA/QC) of different middle and large sized companies producing biopharmaceutical API’s, sterile injectable and sterile ophthalmic under cGMP. He has been Swiss Qualified Person and is working in pharmaceutical quality for more than 20 years. Eric studied organic chemistry, pharmacology and toxicology, and received his PhD in chemistry at the University of Zürich. Today he also acts as industry lecturer for pharmaceutical quality management at the Swiss Federal Institute of Technology (ETH Zürich), University of Basel and the University of Applied Sciences and Arts Northwestern Switzerland.